74 / 100

Dr. Maryam Hossini | Microbiology | Best Researcher Award

Dr. Maryam Hossini, Shiraz university of medical sciences, Iran

Dr. Maryam Hosseini is a distinguished Iranian immunologist specializing in immune-mediated diseases, including cancer immunology, inflammation, trauma, and extracellular vesicles. Born in 1988, she has dedicated her career to advancing immunology through research and teaching. She holds a Ph.D. in Immunology from Tarbiat Modares University, an MSc from Tabriz University of Medical Sciences, and a BSc in Medical Laboratory Science from Shiraz University of Medical Sciences. Dr. Hosseini is an Assistant Professor at Shiraz University of Medical Sciences and has previously contributed to prestigious institutions, including the Middle-East Gene and Cell Therapy Center. Her expertise spans cellular and molecular biology, immunological techniques, and extracellular vesicle research. Recognized for her academic excellence, she ranked first among MSc students and actively contributes to immunology research and education. She is proficient in flow cytometry, real-time PCR, and advanced immunological assays, making her a leading expert in her field.

Professional Profile

Scopus

Google Scholar

Suitability for the Research for Best Researcher Award – Maryam Hosseini

Dr. Maryam Hosseini has demonstrated an outstanding academic and research profile in the field of immunology, particularly in immune-mediated diseases, cancer immunology, trauma, and extracellular vesicles. Her extensive educational background, including a Ph.D. in Immunology from Tarbiat Modares University, combined with a strong research focus, makes her a competitive candidate for the Research for Best Researcher Award. Her Ph.D. research on the impact of miRNA-34a-enriched exosomes in colorectal cancer immunotherapy highlights her expertise in cutting-edge biomedical research.

Dr. Hosseini’s contributions extend beyond theoretical research, as she possesses advanced laboratory skills in cellular and molecular biology, flow cytometry, extracellular vesicle isolation, and immunological assays. These technical competencies are critical in experimental immunology and translational medicine. Her employment history, including her current role as an Assistant Professor at Shiraz University of Medical Sciences, further reinforces her commitment to academia and research. Additionally, her engagement with scientific communities, such as the Immunology and Allergy Committee of Iran, underscores her active participation in advancing the field.

🎓 Education 

Dr. Maryam Hosseini’s academic journey reflects her dedication to immunology. She earned her Ph.D. in Immunology from Tarbiat Modares University, Iran, where her thesis explored the impact of CT-26 cell-line-derived exosomes enriched with miRNA-34a on anti-tumor immune responses in colorectal cancer. Her MSc from Tabriz University of Medical Sciences focused on T lymphocyte activation mechanisms via Leishmania major LPG3 and TLR2 signaling. During her BSc at Shiraz University of Medical Sciences, she gained extensive laboratory experience in medical sciences. Her academic performance was exceptional, graduating with top scores (Ph.D. 18.12/20, MSc 17.38/20, BSc 17.94/20). She has attended specialized workshops in molecular biology, flow cytometry, bioinformatics, and real-time PCR analysis, enhancing her technical expertise. Her commitment to education and research has positioned her as a key figure in immunology, contributing to advancements in immune therapies and inflammation-related diseases.

💼 Professional Experience 

Dr. Hosseini is an Assistant Professor at Shiraz University of Medical Sciences (2022–present), where she teaches immunology and conducts cutting-edge research in immune-mediated diseases. She previously worked at the Middle-East Gene and Cell Therapy Center (2021–2022), contributing to advancements in genetic and cellular therapies. Earlier in her career, she worked at Iran’s Blood Transfusion Institute, where she honed her expertise in immunological assays and transfusion medicine. Her involvement in the 13th International Congress of Immunology and Allergy of Iran (2016, 2018) highlights her active participation in the scientific community. She has also contributed as an executive member in scientific events promoting immunology education. Her extensive laboratory skills in cellular biology, flow cytometry, and molecular techniques, combined with her academic leadership, have made her a pivotal figure in immunological research and teaching, impacting both academia and clinical applications.

🏅 Awards and Recognition 

Dr. Maryam Hosseini’s excellence in immunology has been recognized through various awards and honors. She ranked first among MSc students, demonstrating outstanding academic achievement. She is an esteemed member of the Immunology and Allergy Committee of Iran, contributing to national research initiatives. Her active role in the Student Scientific Association of Stem Cells and Regenerative Medicine showcases her dedication to fostering scientific advancements. Dr. Hosseini has also received accolades for her contributions to international immunology congresses. Her research in cancer immunotherapy and inflammation has gained widespread recognition, further establishing her as a thought leader in the field. Her commitment to laboratory excellence, evident through her expertise in advanced techniques like flow cytometry and extracellular vesicle characterization, has earned her respect among peers. Through her work in academia and research, she continues to impact the global scientific community.

🌍 Research Skills On Microbiology

Dr. Hosseini’s research expertise spans immune-mediated diseases, cancer immunology, inflammation, trauma, and extracellular vesicles. She is proficient in cellular biology techniques, including adherent and suspended cell cultures, mesenchymal stem cell handling, and MACS sorting. Her molecular biology skills include DNA/RNA extraction, qPCR, RT-PCR, and primer design. She excels in flow cytometry analysis, immunological assays (ELISA, Western blotting, cytokine assays), and extracellular vesicle isolation and characterization using ultrafiltration, TEM, and DLS. Her expertise in animal models includes tumor transplantation and immune response evaluation. Dr. Hosseini has participated in advanced workshops on molecular diagnostics, bioinformatics, and quality control in molecular laboratories. Her ability to integrate advanced immunological techniques with translational research makes her a leader in immunotherapy and inflammation studies. Her research contributes significantly to understanding immune system interactions, aiding in the development of novel therapies for immune-mediated diseases.

📖 Publication Top Notes

  • The use of nanoparticles as a promising therapeutic approach in cancer immunotherapy
    Authors: M Hosseini, M Haji-Fatahaliha, F Jadidi-Niaragh, J Majidi, M Yousefi
    Citation Count: 94
    Year: 2016
  • CAR-modified T-cell therapy for cancer: an updated review
    Authors: M Haji-Fatahaliha, M Hosseini, A Akbarian, S Sadreddini, …
    Citation Count: 75
    Year: 2016
  • Reduction and exhausted features of T lymphocytes under serological changes, and prognostic factors in COVID-19 progression
    Authors: A Mahmoodpoor, M Hosseini, S Soltani-Zangbar, S Sanaie, …
    Citation Count: 39
    Year: 2021
  • Tumor-derived exosomes encapsulating miR-34a promote apoptosis and inhibit migration and tumor progression of colorectal cancer cells under in vitro condition
    Authors: M Hosseini, K Baghaei, D Amani, M Ebtekar
    Citation Count: 29
    Year: 2021
  • The anti-tumor effects of CT-26 derived exosomes enriched by MicroRNA-34a on murine model of colorectal cancer
    Authors: M Hosseini, K Baghaei, M Hajivalili, MR Zali, M Ebtekar, D Amani
    Citation Count: 24
    Year: 2022
  • Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges
    Authors: M Hajivalili, M Hosseini, M Haji-Fatahaliha
    Citation Count: 23
    Year: 2020
  • Recombinant LPG3 stimulates IFN-Γ and TNF-A secretion by human NK cells
    Authors: S Rasolzadeh, MH Fatahaliha, M Hosseini, R Jafari, A Miahipour, …
    Citation Count: 18
    Year: 2015
  • Evaluation of miR-200c-3p and miR-421-5p levels during immune responses in the admitted and recovered COVID-19 subjects
    Authors: S Abdolahi, M Hosseini, R Rezaei, SR Mohebbi, M Rostami-Nejad, …
    Citation Count: 16
    Year: 2022
  • T Helper 1 (Th1), Th2, and Th17 Responses to Leishmania major Lipophosphoglycan 3
    Authors: A Miahipour, M Haji-Fatahaliha, H Keshavarz, MJ Gharavi, H Mohamadi, …
    Citation Count: 16
    Year: 2016
  • Application of newly developed SARS-CoV2 serology test along with real-time PCR for early detection in health care workers and on-time plasma donation
    Authors: MS Soltani-Zangbar, L Aghebati-Maleki, M Hajivalili, M Haji-Fatahaliha, …
    Citation Count: 12
    Year: 2021
Maryam Hossini | Microbiology | Best Researcher Award

You May Also Like